Stock Taper
SCREENER COMPARE ANY 2 STOCKS
INBS
INTELLIGENT BIO SOLUTIONS INC.
NASDAQ
$2.36
▲ UP 3.96% (0.09)

KEY STATISTICS

Market Cap$1.52 M
52w High$24.90
52w Low$1.52
Dividend Yield—
Frequency—
P/E-0.24
Volume16.77K
Shares Out.645.75K

COMPANY

LEADERSHIP

Harry Simeonidis
CHIEF EXECUTIVE
Harry Simeonidis

COMPENSATION 2026

Salary$366,250
Stock Awards$56,945
Incentive Plan Pay$0
All Other Comp.$59,476
Total$482,671

ABOUT

SECTOR
Healthcare
WENT PUBLIC
December 23, 2020
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
58

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.$1.42M
NOV
11
WED

SPLIT RECORD

DATETYPERATIO
2025-12-16Reverse1:10
2024-01-29Reverse1:12
2023-02-10Reverse1:20

PRICE

$2.36 ▲ UP 3.96% (+$0.09)
OVERLAYS
$2.30$2.35$2.409:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM2.36

About Intelligent Bio Solutions Inc.

https://ibs.inc ↗

Intelligent Bio Solutions Inc. develops non-invasive, real-time biosensors for health monitoring, including saliva glucose and SARS-CoV-2 tests, serving patients and practitioners, and is based in New York.

INDUSTRY

Medical - Devices

A PRODUCT INTELLIGENT BIO SOLUTIONS INC. IS KNOWN FOR

Intelligent Fingerprinting Drug Screening System
Intelligent Fingerprinting Drug Screening System

A portable, non-invasive fingerprint sweat test detects recent use of drugs like cannabis, cocaine, opiates, and methamphetamine in under ten minutes, offering a hygienic alternative to urine or saliva screening for workplaces and law enforcement.

COMPETITORS

COMPETITOR
ABT COMPARE
DGX COMPARE
LH COMPARE
OSUR COMPARE
QDEL COMPARE

Revenue by Products

IconPRODUCTQ1-2025Q2-2025Q3-2025Q4-2025
Other Sales$189.99K $98.41K ▼$121.04K ▲$169.21K ▲

Revenue by Geography

MapREGIONQ4-2025Q2-2026Q3-2026Q4-2026
Asia Pacific— $1.54K $3.67K ▲$7.25K ▲
Americas— $7.63K $4.09K ▼$0 ▼
Other Country$31.6K $40.73K ▲$11.89K ▼$0 ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
VXF
0.00% · 5.8K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
100.00%
HOLDERS
14
TOP 12 OF 14 · RANKED BY POSITION SIZE
Alyeska Investment Group, L.P.
673.5K sh · $686.96K
Adar1 Capital Management, LLC
426.4K sh · $434.96K
Vanguard Group Inc
97.7K sh · $99.64K
Cvi Holdings, LLC
79.8K sh · $153.3K
Geode Capital Management, LLC
58.9K sh · $60.05K
Warberg Asset Management LLC
44.7K sh · $45.59K
Lpl Financial LLC
25.0K sh · $25.5K
Goldman Sachs Group Inc
12.8K sh · $13.09K
Citigroup Inc
9.3K sh · $9.54K
Nbc Securities, Inc.
2.6K sh · $2.69K
Curio Wealth, LLC
2.0K sh · $2.04K
National Bank Of Canada /Fi/
350 sh · $354

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book4
Overall Score2

INSIDER TRADES

★
OFFICER: CHIEF FINANCIAL OFFICER
Sakiris Spiro Kevin
Purchase · 21.4K shares
2026-03-18
★
DIRECTOR
Fraser Nicola Marion
Purchase · 5.0K shares
2026-03-18
★
DIRECTOR
Boyages Steven Constantine
Purchase · 5.0K shares
2026-03-18
★
OFFICER: CHIEF FINANCIAL OFFICER
Sakiris Spiro Kevin
Purchase · 9.2K shares
2026-03-18

SECTORS PEERS

PEERPRICE
PAVM$4.92COMPARE
BNGO$1.17COMPARE
BCLI$1.12COMPARE
HSCS$3.03COMPARE
ADIL$5.60COMPARE
SSKN$0.01COMPARE